Valeant Pharmaceutical International, Inc. : Allergan, Inc. Common Stock District Court Denies Motion To Dismiss Class Action Complaint Relating to Insider Trading and Tender Offer, Clarifies Elements of Section 20A(a) of Exchange Act and SEC Rule 14e-3, and Finds Implied Right of Action Under Rule 14e-3
Rock Center/SVDX Morning Speaker Series Shareholder Activism in Silicon Valley: Good, Bad or just Ugly?Shareholder Activism in Silicon Valley: Good, Bad or just Ugly?
SECURITIES CLASS ACTION FILINGS 2015 Midyear Assessment
Plaintiffs brought 85 new federal class action securities cases in the first half of 2015, compared with 92 in the second half of 2014. The number of filings in the first six months of 2015 remained 10 percent below the semiannual average of 94 observed between 1997 and 2014.
Press Release ·
Full Report
ACCOUNTING CLASS ACTION FILINGS AND SETTLEMENTS 2014 Review and Analysis
Securities class action filings with accounting allegations jump 47 percent in 2014. Accounting cases represent the vast majority of total settlement value.
Press Release ·
Full Report
SECURITIES CLASS ACTION SETTLEMENTS 2014 Review and Analysis
Total settlement dollars in securities class actions hit their lowest mark in 16 years in 2014. The average settlement amount also reached its lowest level since 2000.
Press Release ·
Full Report
